(BMY) Bristol-Myers Squibb - Performance 16.1% in 12m
BMY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-1.17%
#60 in Peer-Group
Rel. Strength
64.54%
#2645 in Stock-Universe
Total Return 12m
16.08%
#48 in Peer-Group
Total Return 5y
-3.02%
#70 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 17.5 |
| P/E Forward | 6.96 |
| High / Low | USD |
|---|---|
| 52 Week High | 62.43 USD |
| 52 Week Low | 38.18 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 24.17 |
| Buy/Sell Signal +-5 | -0.99 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BMY (16.1%) vs XLV (-7.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.67% | 143% | 342% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
9.25% | -11.8% | 416% | 63.7 | 36 | 1.2 | 58.2% | 18.9% |
| NVS NYSE Novartis |
4.23% | 13.9% | 74.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
1.41% | 2.61% | 46.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| GSK NYSE GlaxoSmithKline |
-2.94% | -0.85% | 47.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-7.61% | -1.2% | 117% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| AZN NASDAQ AstraZeneca |
-1.8% | -10.9% | 47.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
1.16% | -10.2% | 43.5% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: BMY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for BMY
| Total Return (including Dividends) | BMY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -0.45% | 1.80% | 3.01% |
| 3 Months | -20.28% | -7.39% | 5.82% |
| 12 Months | 16.08% | -7.13% | 12.82% |
| 5 Years | -3.02% | 47.29% | 114.16% |
| Trend Score (consistency of price movement) | BMY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -22.7% | 54% | 78.3% |
| 3 Months | -66.3% | -57.4% | 87.1% |
| 12 Months | 35.6% | -69.2% | 43.5% |
| 5 Years | -20.8% | 88.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #103 | -2.21% | -3.35% |
| 3 Month | #157 | -13.92% | -24.66% |
| 12 Month | #48 | 24.99% | 2.89% |
| 5 Years | #73 | -34.16% | -54.72% |
FAQs
Does Bristol-Myers Squibb (BMY) outperform the market?
Yes,
over the last 12 months BMY made 16.08%, while its related Sector, the Health Care Sector SPDR (XLV) made -7.13%.
Over the last 3 months BMY made -20.28%, while XLV made -7.39%.
Performance Comparison BMY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BMY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.3% | -3.5% | -19.3% | 3% |
| US NASDAQ 100 | QQQ | -2.8% | -4.4% | -20.2% | 3% |
| German DAX 40 | DAX | -1.1% | 2.6% | -35% | -13% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.9% | -4.7% | -19.9% | -3% |
| Hongkong Hang Seng | HSI | -4.7% | -8.7% | -38.4% | -19% |
| India NIFTY 50 | INDA | -2.6% | -1.3% | -21% | 16% |
| Brasil Bovespa | EWZ | 1.5% | -0.8% | -41.4% | 10% |
BMY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.3% | -4% | -24.6% | -8% |
| Consumer Discretionary | XLY | -1.8% | 1.1% | -9.4% | -3% |
| Consumer Staples | XLP | -0.8% | 1.4% | -19.7% | 10% |
| Energy | XLE | 2.9% | -3.5% | -19.3% | 21% |
| Financial | XLF | -3.1% | -1.7% | -23.2% | -10% |
| Health Care | XLV | -1.3% | -2.3% | -14.5% | 23% |
| Industrial | XLI | -1.8% | -1.1% | -25.5% | -3% |
| Materials | XLB | -0.6% | -0.5% | -20.4% | 16% |
| Real Estate | XLRE | 0.2% | -1.2% | -20.2% | 3% |
| Technology | XLK | -3.7% | -8% | -21.7% | 5% |
| Utilities | XLU | -1% | 0.3% | -24.7% | -4% |
| Aerospace & Defense | XAR | -3% | -5.2% | -36.2% | -28% |
| Biotech | XBI | -1.1% | -5.5% | -7.6% | 27% |
| Homebuilder | XHB | -4.3% | -0.7% | -9.3% | 19% |
| Retail | XRT | -0.8% | -0.8% | -11.7% | 13% |
BMY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.6% | -9.41% | -18.0% | 23% |
| Natural Gas | UNG | 12% | 6.7% | -20.9% | 33% |
| Gold | GLD | 0.7% | -1.3% | -44.1% | -27% |
| Silver | SLV | 0.4% | -9.7% | -39.4% | -9% |
| Copper | CPER | -2% | -4.5% | -37% | 2% |
BMY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.3% | -2.9% | -19.2% | 20% |
| iShares High Yield Corp. Bond | HYG | -1.1% | -1.8% | -21.9% | 6% |